Therefore, one possibility for the conflicting data on the consequences of high HER1 and HER2 expression in bladder cancer patients published until now could be related to the function of HER3 or HER4 expression, which was ignored in most of the studies. The gene discussed is ERBB4; the disease is urinary bladder carcinoma.